Lazard Appoints Pranjal Gambhir as Head of Medical Technology

NEW YORK, Sept. 28, 2026 /CourierPR/ -- Lazard, the preeminent financial advisory and asset management firm, has appointed Pranjal Gambhir as the Head of Medical Technology, based in New York. This move marks a significant addition to the firm’s healthcare practice, enhancing its ability to advise clients on strategic and corporate development transactions within the Medical Technology sector.

Gambhir brings extensive experience to the role, having spent 20 years at Citi, where he covered Medical Technology companies across multiple sub-sectors. His background spans both New York and New Delhi, providing him with a broad perspective on the global Medical Technology landscape.

In his new role, Gambhir will lead coverage of Medical Technology companies, advising clients on strategy and corporate development transactions. The Medical Technology sector continues to evolve rapidly, creating both opportunity and complexity for clients. Lazard's independent perspective and global platform are well-suited to help leadership teams, boards, and investors navigate these challenges.

Pranjal earned his MBA from the Indian School of Business and his Bachelor of Commerce from Delhi University. Founded in 1848, Lazard provides advice on mergers and acquisitions, capital markets and capital solutions, restructuring and liability management, geopolitics, and other strategic matters, as well as asset management and investment solutions to institutions, corporations, governments, partnerships, family offices, and high net worth individuals.

With the addition of Gambhir, Lazard aims to further strengthen its position in the healthcare sector, ensuring that it remains at the forefront of advisory services for Medical Technology companies.